💊 Tiotropium (Tiotropium Bromide)
Tiotropium is an inhalation powder used once daily as long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is also used to reduce COPD exacerbations. It is not a rescue medication for acute episodes.
In Arabic: تيوتروبيوم (بروميد التيوتروبيوم)✅ What it is used for
- Long-term, once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema
- Reduction of exacerbations in COPD patients
🧪 Active ingredient
The active ingredient is tiotropium, a long-acting antimuscarinic (anticholinergic) agent. It inhibits M3 receptors on airway smooth muscle, leading to bronchodilation.
🌿 Benefits
- Opens the airways and relieves bronchospasm associated with COPD
- Once-daily long-term maintenance treatment
- Reduces COPD exacerbations
📝 How to use
- For oral inhalation only. Do not swallow the capsules, as the intended effects on the lungs will not be obtained.
- Use the capsule contents only with the LupinHaler device.
- The capsule is placed in the center chamber of the device, pierced by pressing and releasing the green button, and the powder is inhaled through the mouthpiece.
- The dose is set by your doctor or pharmacist; the label's recommended dose is two inhalations of the contents of one capsule once daily.
- Do not take more than one dose in 24 hours.
- Keep capsules in the blister and remove only immediately before use; do not store them in the device.
💊 Dosage forms
- Inhalation powder capsules containing 18 mcg tiotropium (equivalent to 22.5 mcg tiotropium bromide monohydrate), supplied with the LupinHaler device
⚠️ Common side effects
- Dry mouth (most common; usually mild and often resolves with continued treatment)
- Upper respiratory tract infection
- Sinusitis
- Pharyngitis
- Non-specific chest pain
- Urinary tract infection
- Dyspepsia
- Rhinitis
- Constipation
- Tachycardia
- Blurred vision
- Painful or difficult urination
🚨 Serious — seek medical help
- Immediate hypersensitivity reactions: urticaria, angioedema (swelling of lips, tongue or throat), rash, itching, bronchospasm, anaphylaxis — stop the drug at once and seek medical help
- Paradoxical bronchospasm
- Worsening of narrow-angle glaucoma
- Worsening of urinary retention
⛔ Do not use if
- Hypersensitivity to tiotropium, ipratropium, or any component of the product
❗ Warnings & precautions
- Not for acute use: not a rescue medication for sudden bronchospasm.
- If an immediate hypersensitivity reaction occurs, stop therapy at once and consider alternatives.
- Patients with a history of hypersensitivity to atropine or its derivatives should be closely monitored.
- Use with caution in patients with severe hypersensitivity to milk proteins (the powder contains lactose that may contain milk proteins).
- May cause paradoxical bronchospasm; discontinue and consider other treatments.
- Use with caution in narrow-angle glaucoma; consult a physician immediately if symptoms worsen.
- Use with caution in prostatic hyperplasia or bladder-neck obstruction; consult a physician immediately if symptoms worsen.
- Patients with moderate to severe renal impairment should be monitored closely for anticholinergic effects.
- Avoid getting the powder into the eyes.
🔄 Drug interactions
- Other anticholinergics: potential additive interaction; avoid coadministration with other anticholinergic-containing drugs as this may increase anticholinergic adverse effects.
- Has been used with short- and long-acting beta-agonists, methylxanthines, and oral and inhaled steroids without increased adverse reactions.
🤰 Pregnancy
Limited human data are insufficient to inform a drug-associated risk in pregnancy. In animal studies no structural abnormalities were observed, but increased post-implantation loss occurred at maternally toxic doses. Consult your doctor before use during pregnancy.
🍼 Breastfeeding
The provided label text contains no information on breastfeeding; consult your doctor or pharmacist.
🧒 Children
Not indicated for use in children; safety and effectiveness in pediatric patients have not been established.
👴 Older adults
No dosage adjustment is warranted in geriatric patients. Dry mouth, constipation and urinary tract infections were reported more often with increasing age.
🌡️ Storage
Store at 20–25°C (excursions permitted to 15–30°C). Keep capsules in the blister, away from extreme temperature or moisture, and do not store them in the LupinHaler device. Keep out of reach of children.
⏰ Missed dose
The provided label text gives no specific instructions for a missed dose. Do not take more than one dose in 24 hours, and ask your doctor or pharmacist if you miss a dose.
🆘 Overdose
High doses may cause anticholinergic signs and symptoms such as dry mouth and conjunctivitis. Treatment consists of discontinuing the drug with symptomatic and/or supportive therapy. Acute intoxication from accidental ingestion of capsules is unlikely because of poor systemic absorption, but one postmarketing case of inhaling 30 capsules over 2.5 days resulted in altered mental status, tremors, abdominal pain and severe constipation. Seek medical help immediately.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Tiotropium is a long-acting antimuscarinic with similar affinity for muscarinic receptor subtypes M1–M5. Inhibition of M3 receptors on airway smooth muscle leads to bronchodilation. Antagonism is competitive and reversible; in preclinical studies, prevention of methacholine-induced bronchoconstriction was dose-dependent and lasted longer than 24 hours. Bronchodilation is predominantly a site-specific effect.
Labeled dosing
General adult dosing per label: two inhalations of the powder contents of one 18 mcg capsule once daily via the LupinHaler device; do not exceed one dose in 24 hours. No dose adjustment is required for geriatric, hepatically impaired or renally impaired patients, but patients with moderate to severe renal impairment should be monitored closely for anticholinergic effects.
- Indication: maintenance treatment of COPD bronchospasm and reduction of exacerbations; not for rescue use.
- Contraindicated in hypersensitivity to tiotropium, ipratropium, or any component.
- Avoid coadministration with other anticholinergic-containing drugs.
- In a 198-patient QT study, more patients had baseline-corrected QTc increases of 30–60 msec with tiotropium than placebo, with no patient exceeding 500 msec; other studies did not detect an effect on QTc.
- Label text provided contains no lactation data.
🎓 Key points for students
- Class: long-acting antimuscarinic (anticholinergic) administered by inhalation.
- Mechanism: competitive, reversible M3 receptor antagonism in airway smooth muscle causing bronchodilation.
- Indication: COPD maintenance therapy and reduction of exacerbations; not a rescue drug.
- Dose: 18 mcg (two inhalations from one capsule) once daily via LupinHaler.
- Most common adverse effect: dry mouth; important risks: hypersensitivity, paradoxical bronchospasm, worsening narrow-angle glaucoma and urinary retention.
- Contraindication: hypersensitivity to tiotropium/ipratropium/components; contains lactose that may contain milk proteins.
- Key interaction: additive effect with other anticholinergics.
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
Can I use tiotropium during a sudden shortness-of-breath attack?
No. It is a once-daily maintenance treatment and should not be used for relief of acute symptoms or as rescue therapy.
Should I swallow the capsule?
No. The capsules are for oral inhalation only, using the LupinHaler device. Swallowing them will not give the intended effect on the lungs.
What are the most common side effects?
Dry mouth is most common and is usually mild. Others include upper respiratory tract infection, sinusitis, pharyngitis, dyspepsia and chest pain.
When should I stop and contact a doctor right away?
If you develop swelling of the lips, tongue or throat, itching, rash, sudden breathing difficulty after inhaling, worsening eye pain, or difficulty urinating.
Can it be used with my other COPD or asthma medicines?
It has been used with beta-agonists, methylxanthines and steroids without increased adverse reactions, but other anticholinergic drugs should be avoided. Always check with your doctor or pharmacist.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-10), simplified. Updated: 2026-11-16.